# TheraSphere for the Treatment of Liver Metastases

> **NCT00511862** · PHASE2 · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 151 (actual)

## Conditions studied

- Colorectal Cancer
- Carcinoma, Neuroendocrine
- Neoplasm Metastasis

## Interventions

- **DEVICE:** Yttrium 90 glass microspheres

## Key facts

- **NCT ID:** NCT00511862
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2021-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00511862

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00511862, "TheraSphere for the Treatment of Liver Metastases". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00511862. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*